EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement

Davide Fattore iD, Zoe Apalla iD, Azael Freites-Martinez iD, Nello Tommasino iD, Vasiliki Nikolaou iD, Giuseppe Lauletta iD, Ariadna Ortiz-Brugues iD, Pietro Sollena, Michela Starace iD, Nuno Miguel Preto Gomes iD, Dimitra Koumaki iD, Emmanuelle Vigarios und 4 weitere

Journal of the European Academy of Dermatology and Venereology · 2026-05 · 40 (5) · 739-759

DOI: 10.1111/jdv.70149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 30.10.2025. Verfasst von Davide Fattore und 15 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Immunotherapy, Drug Eruptions, Skin Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 151 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy, particularly immune checkpoint inhibitors (ICI), has revolutionized oncology treatment by leveraging the immune system to recognize and eliminate cancer cells. However, despite its efficacy, immunotherapy may induce immune‐related adverse events (irAEs), including dermatological events, that can range from mild rashes to severe life‐threatening conditions such as toxic epidermal necrolysis. This paper aims to explore and analyse the preventive measures for cutaneous irAEs (cirAEs). By identifying risk factors, recognizing early signs and implementing preventive strategies, healthcare professionals can significantly mitigate the severity of irAEs, thereby improving patient outcomes and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsImmunotherapyDrug EruptionsSkin DiseasesHumansRisk FactorsStevens-Johnson SyndromeAdvisory Committees

Stichwörter der Autor:innen

immune checkpoint inhibitorsimmune‐related adverse eventsimmunotherapyipilimumabnivolumaboncodermatologypembrolizumabpreventative strategies

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Second Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Dermatology, Hospital Ruber de Juan Bravo, Universidad Europea, Madrid, Spain.
  • Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
  • Department of Oncodermatology, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
  • Dermatology Unit, Department of Surgical and Medical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

ORCID-Profile: Davide Fattore, Zoe Apalla, Azael Freites-Martinez, Nello Tommasino, Vasiliki Nikolaou, Giuseppe Lauletta, Ariadna Ortiz-Brugues, Michela Starace, Nuno Miguel Preto Gomes, Dimitra Koumaki, Katerina Grafanaki, Maddalena Napolitano, Vincent Sibaud

Zitieren

APA

Fattore, D., Apalla, Z., Freites-Martinez, A., Tommasino, N., Nikolaou, V., Lauletta, G., Ortiz-Brugues, A., Sollena, P., Starace, M., Gomes, N. M. P., Koumaki, D., Vigarios, E., Kraehenbuehl, L., Grafanaki, K., Napolitano, M., & Sibaud, V. (2026). Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement. Journal of the European Academy of Dermatology and Venereology, 40(5), 739-759. https://doi.org/10.1111/jdv.70149

Vancouver

Fattore D, Apalla Z, Freites-Martinez A, Tommasino N, Nikolaou V, Lauletta G, et al. Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement. Journal of the European Academy of Dermatology and Venereology. 2026;40(5):739-759. doi:10.1111/jdv.70149

BibTeX
@article{Fattore2026,
  author = {Fattore, Davide and Apalla, Zoe and Freites-Martinez, Azael and Tommasino, Nello and Nikolaou, Vasiliki and Lauletta, Giuseppe and Ortiz-Brugues, Ariadna and Sollena, Pietro and Starace, Michela and Gomes, Nuno Miguel Preto and Koumaki, Dimitra and Vigarios, Emmanuelle and Kraehenbuehl, Lukas and Grafanaki, Katerina and Napolitano, Maddalena and Sibaud, Vincent},
  title = {Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {5},
  pages = {739--759},
  doi = {10.1111/jdv.70149}
}
Kostenlos starten →